ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Zhe Cao
Matched on OpenAlex author ID A5104074117. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 5
- TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated DNA damage repair and IRS2 expression i… Co-author DOI 10.1016/j.canlet.2026.218725↗
- SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Co-author DOI 10.1002/mc.23936↗
- Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. Co-author DOI 10.1016/j.canlet.2025.218016↗
- Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. First author DOI 10.1097/sla.0000000000001345↗
- Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study. Co-author DOI 10.18632/oncotarget.9491↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taiping Zhang · 4 shared papers, 2016–2025 · strength 0.57
- Paper Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. DOI 10.1016/j.canlet.2025.218016↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Paper Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. DOI 10.1097/sla.0000000000001345↗
- Jianchun Xiao · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Yueze Liu · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Wenhao Luo · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Yifan Fu · 2 shared papers, 2025–2026 · strength 0.43
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocar… DOI 10.1002/mc.23936↗
- Lei You · 3 shared papers, 2016–2026 · strength 0.34
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Paper Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. DOI 10.1097/sla.0000000000001345↗
- Paper Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study. DOI 10.18632/oncotarget.9491↗
- Bo Ren · 1 shared paper, 2025 · strength 0.27
- Shijuan Jiang · 1 shared paper, 2025 · strength 0.27
- Yupei Zhao · 1 shared paper, 2026 · strength 0.24
- Yuanyang Wang · 1 shared paper, 2026 · strength 0.24
- Tao Liu · 1 shared paper, 2025 · strength 0.20
- Jinxin Tao · 1 shared paper, 2025 · strength 0.20
- Hao Chen · 1 shared paper, 2025 · strength 0.20
- Hua Huang · 1 shared paper, 2025 · strength 0.20
- Yuanyang Wang · 1 shared paper, 2025 · strength 0.20
- Jun Wang · 1 shared paper, 2025 · strength 0.20
- Jiangdong Qiu · 1 shared paper, 2025 · strength 0.20
- Bei Sun · 2 shared papers, 2016 · strength 0.11
- Jianwei Xu · 2 shared papers, 2016 · strength 0.11
- Yi Miao · 2 shared papers, 2016 · strength 0.11
- Chunyou Wang · 2 shared papers, 2016 · strength 0.11
- Wenhui Lou · 2 shared papers, 2016 · strength 0.11
- Yupei Zhao · 2 shared papers, 2016 · strength 0.11
- Li Zhou · 1 shared paper, 2016 · strength 0.05
- Xubao Liu · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.